Real-time Feedback of Red-out Within Colonoscopy Intubation
Prospective, Multicenter, Controlled Study on the Impact of Real-time Feedback on Red-out
1 other identifier
interventional
576
0 countries
N/A
Brief Summary
This study will employ a prospective, multicenter, controlled design. It will be conducted across multiple centers, with participated centers randomly assigned to one of four groups: Group A, Group B, Group C, and Group D. The research will primarily focus on the AI-based analysis of colonoscopic images to calculate the following metrics: caecal intubation time, red-out percentage, and the AI-based red-out avoiding score. Based on the study's implementation protocol, a decision will be made regarding whether to provide real-time feedback. Additionally, the presence of any complications will be assessed both during and after the colonoscopy procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Dec 2025
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 27, 2025
CompletedFirst Posted
Study publicly available on registry
December 10, 2025
CompletedStudy Start
First participant enrolled
December 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
April 20, 2028
December 10, 2025
October 1, 2025
1.7 years
November 27, 2025
November 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Red-out percentage
The impact of real-time feedback on red-out percentage.
Stage 3 (projected to begin in 3-6 months)
Caecal intubation time
The impact of real-time feedback on caecal intubation time.
Stage 3 (projected to begin in 3-6 months)
AI-based red-out avoiding score
The impact of real-time feedback on AI-based red-out avoiding score.
Stage 3 (projected to begin in 3-6 months)
Secondary Outcomes (1)
Complications
Stage 3 (projected to begin in 3-6 months)
Study Arms (4)
Group A
SHAM COMPARATORDuring colonoscopy intubation, AI system is used to calculate and analyze "caecal intubation time," "red-out percentage," and the "AI-based red-out avoiding score" in real-time; however, these results are not provided as feedback to the operating colonoscopist.
Group B
EXPERIMENTALDuring colonoscopy intubation, AI system is used to calculate and analyze "caecal intubation time," "red-out percentage," and the "AI-based red-out avoiding score" in real-time, with only the caecal intubation time being provided as feedback to the operator, while the red-out percentage and AI-based red-out avoiding score are withheld.
Group C
EXPERIMENTALDuring colonoscopy intubation, AI system is used to calculate and analyze "caecal intubation time," "red-out percentage," and the "AI-based red-out avoiding score" in real-time, with only the red-out percentage being provided as feedback to the operator, while the caecal intubation time and AI-based red-out avoiding score are withheld.
Group D
EXPERIMENTALDuring colonoscopy intubation, AI system is used to calculate and analyze the "caecal intubation time" "red-out percentage," and "AI-based red-out avoiding score" in real-time, with all three results provided as feedback to the operating colonoscopist.
Interventions
AI-system Performance Feedback in group B, group C, and group D.
Eligibility Criteria
You may qualify if:
- Study Participants (Patients):
- Aged 18 to 70 years, any gender. Individuals scheduled to undergo diagnostic or screening colonoscopy at the investigational site.
- Colonoscopists:
- Expert-level colonoscopists (having performed a total of \>1000 colonoscopy procedures).
- Right-handed.
You may not qualify if:
- Study Participants (Patients):
- Individuals undergoing the following procedures:
- cases with a history of colorectal surgery; cases with a history of chemotherapy, raditherapy; cases with a history of abdominal, and/or pelvic surgery; cases with a history of difficult colonoscopies; cases with colorectal tumours and obstructive lesions; cases with colorectal diverticula; cases with ulcerative colitis or Crohn's disease; cases with ischemic bowel disease; cases with colorectal polyposis; cases with melanosis coli; cases undergoing sigmoidoscopy; cases with poor intestional cleanliness (segment Boston bowel preparation scale (BBPS) of \< 2 points, total BBPS of \< 6 points); cases undergoing therapy procedures such as biopsy or CSP during the intubation phase; cases with transparent cap assisted colonoscopy; cases with water-assisted colonoscopy; cases with air insufflation level of M or L; cases failed caecal intubation within 15 min; cases with colonoscope stiffness level \> 0; obese cases or underweight cases; and cases refusing participation.
- Individuals who decline to provide informed consent.
- Colonoscopists:
- Those who have performed fewer than 300 complete colonoscopies in any calendar year within the past three years.
- Those who decline to participate in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 27, 2025
First Posted
December 10, 2025
Study Start
December 10, 2025
Primary Completion (Estimated)
August 31, 2027
Study Completion (Estimated)
April 20, 2028
Last Updated
December 10, 2025
Record last verified: 2025-10